We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT01240694
Previous Study | Return to List | Next Study

A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Patients With Systemic Lupus Erythematosus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01240694
Recruitment Status : Terminated (Business Decision; there were no safety issues)
First Posted : November 15, 2010
Last Update Posted : July 21, 2016
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Cephalon )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : September 2012
  Study Completion Date : September 2012
  Certification or Request for Extension to Delay Results Submission: September 9, 2013